Australia–China FTA (ChAFTA) – Origin Cumulative Medical Technology

Quelle: https://www.dfat.gov.au/trade/agreements/negotiating/chafta/Pages/australia-china-fta-fact-sheets

The Australia–China Free Trade Agreement (ChAFTA) allows for origin cumulative treatment for medical technology, meaning materials from both countries can be used to meet the origin rules to gain tariff benefits.

Related Terms

You might also be interested in these terms

Australia–China FTA (ChAFTA) – Origin Cumulative Footwear

Origin cumulative under the Australia-China Free Trade Agreement (ChAFTA) allows companies to use materials and components from certain countries to m...

Learn more

Australia-China FTA (ChAFTA) – Origin Cumulation Rubber

The origin cumulation rubber under the Australia-China FTA (ChAFTA) allows rubber produced in Australia to be recognized as a product of origin in the...

Learn more

China–Chile FTA – Origin Cumulativity Medical Technology

The China–Chile Free Trade Agreement (FTA) allows for origin cumulativity for medical technology products, meaning that Chile and China benefit from c...

Learn more

EFTA–China FTA – Origin Cumulation Medical Technology

Origin cumulation under the EFTA–China Free Trade Agreement allows EFTA countries and China to combine their production components in such a way that ...

Learn more

CAFTA-DR – Origin Cumulation Medical Technology

The origin cumulation under CAFTA-DR allows companies to combine materials and components from member countries to meet the origin rules for medical t...

Learn more

Australia–China FTA (ChAFTA) – Origin Cumulation Chemicals

Origin cumulation under the Australia–China FTA (ChAFTA) allows businesses to consider chemical products produced in Australia or China as originating...

Learn more